Medidata Launches New Clinical Operations Technologies
Enhancements to Medidata Detect and Rave CTMS will improve both data oversight and reporting for sponsors and CROs.
Medidata announced technology enhancements that address key issues in clinical trial management and oversight. Enhancements to Medidata Detect and Rave CTMS will improve both data oversight and reporting for sponsors and contract research organizations in two ways: how they comprehensively monitor their trial data, and how they visualize those data to make faster decisions.
Read more about the enhacnements
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
